S&P 500Dow JonesNASDAQ 100DAX 40MDAXSDAXTecDAXATXSMICAC 40AEXBEL 20IBEX 35
Home/S&P 500/Bio-Techne
Bio-Techne

Bio-Techne

TECHS&P 500
72,13 $
Dividend yield0,22 %
Continuity14 yr
Dividend0,16 $
DiviScore
59SCOREGood
Performance26/35
Dividend Quality18/35
AGM Date
Ex-Date
18.05.2026
Payment
CAGR 3Y
-4.2%
CAGR 5Y
-9.8%
CAGR 10Y
+9.9%

€10,000 invested in 2016 · with dividend reinvestment

+170%
End Value
27.008,07 $
Total Return
+170.1%
Annual Return
10.4% p.a.
Dividends Received
1.161,44 $

Dividend history

14 years continuous
YearAmountDividend yieldAGM dateEx-datePayment dateChange
20260,16 $18.05.2026-50.0%
20250,32 $17.11.2025+100.0%
20240,16 $08.11.2024-50.0%
20230,32 $09.11.20230.0%
20220,32 $10.11.20220.0%
20210,32 $10.11.20210.0%
20200,32 $13.11.20200.0%
20190,32 $07.11.20190.0%
20180,32 $08.11.20180.0%
20170,32 $09.11.20170.0%

About Bio-Techne

Bio-Techne Corporation is a global life sciences company that develops, manufactures, and supplies specialized tools for research and clinical diagnostics. The company focuses on high-quality reagents, analytical instruments, and precision diagnostic products used across pharmaceutical, biotechnology, academic, and clinical laboratory settings. Through its protein sciences activities, Bio-Techne provides antibodies, bioactive proteins, assays, and related instruments that support investigations into cellular pathways, disease mechanisms, and therapeutic targets. Its diagnostics and spatial biology offerings include diagnostic reagents, molecular diagnostic solutions, and advanced platforms for visualizing and quantifying biomolecules in tissues, supporting pathology and translational research. Bio-Techne serves a diversified customer base involved in drug discovery, basic and applied research, and high-complexity diagnostic testing, helping ensure reproducible and consistent experimental results. Incorporated in 1981 and headquartered in Minneapolis, Minnesota, Bio-Techne today plays a significant role in the global life sciences infrastructure by providing critical consumables and instruments that are embedded in laboratory workflows worldwide.

IndustryBiotechnology
SectorHealthcare
KGV (PE)102.93
Payout Ratio45.7%
ROE5.3%

Frequently Asked Questions

The next payment date is not yet announced.
Bio-Techne has a DiviScore of 59/100. DiviScore rates dividend stocks based on price performance, dividend quality, fundamentals, and stability.
Bio-Techne's current dividend yield is 0.22% based on the latest dividend.
Bio-Techne (TECH) is a member of S&P 500. Current data including price, dividend, and DiviScore is updated daily.
DiviScore is a proprietary 100-point rating based on four pillars: Performance (35 pts), Dividend Quality (35 pts), Fundamentals (15 pts), and Stability (15 pts). It simulates a 10-year investment with automatic dividend reinvestment.